Invacare
Corporate brand
UnclaimedInvacare is a global medical-equipment brand focused on mobility, rehabilitation, patient handling, beds, seating and pressure-care products.
Last updated August 31, 2026
AI crawler reads
No AI crawler has read this profile yet.
Overview
Invacare is a medical-device brand and manufacturer associated with non-acute healthcare equipment for people with disabilities, older adults, rehabilitation patients and individuals requiring assistance with mobility or daily living. Its principal product areas include manual and powered wheelchairs, mobility scooters, adjustable and medical beds, patient-lifting and safe-handling equipment, pressure-care systems, and specialized seating and positioning products. The company has historically served both institutional and home-care settings through medical-equipment providers, distributors and healthcare channels. The business has a long manufacturing lineage. Its history is traced to the Worthington Company, which began producing wheelchairs in 1885. Although its product range broadened over time, wheelchair manufacturing remained an important foundation. During the 1970s, the business was owned by Technicare, a Cleveland medical-device company. Under the marketing leadership of Malachi A. Mixon, Invacare expanded beyond traditional wheelchair products and entered diagnostic imaging. Technicare was acquired by Johnson & Johnson in 1978, after which Invacare was offered for sale. Mixon pursued the acquisition as an opportunity to operate his own company. He financed the transaction through a combination of borrowing and additional fundraising, completing the purchase on December 28, 1979, for $7.8 million. Under his leadership, Invacare developed through organic expansion and acquisitions, building a broader portfolio of rehabilitation and home-medical equipment. By 2008, after multiple acquisitions, the company was reported to have a valuation of approximately $1.8 billion and to supply products through more than 25,000 medical-equipment providers in 80 countries. Invacare's business has also been shaped by regulatory requirements. In 2012, its North American operations entered into a consent decree with the United States federal government concerning specified products and facilities. Subsequent certification work by an independent auditor and inspections by the U.S. Food and Drug Administration addressed design controls and design-history documentation. The FDA accepted two certification reports by 2013, while a 2015 follow-up inspection identified further work. In 2017, the agency accepted a revised second report, allowing design work to resume at the company's Elyria facility; review of a further certification report remained dependent on resolution of the earlier discrepancies. The company experienced significant financial pressure in North America and announced in February 2023 that certain North American entities had filed for protection under Chapter 11 of the U.S. Bankruptcy Code. The filing did not cover the entire international business. Invacare subsequently emerged from Chapter 11 in 2024 and continued operating across North America, Europe and Asia-Pacific, with additional international distribution. Its brand remains associated with practical, function-oriented medical equipment rather than acute-care hospital technology, with an emphasis on mobility, independence, caregiver support and home-based care.
History
Invacare's industrial lineage reaches back to 1885, when the Worthington Company began producing wheelchairs. The company expanded its product lines over subsequent decades, but mobility equipment remained central to its identity. During the 1970s, Invacare was owned by Technicare, a Cleveland-based medical-device manufacturer. Under Malachi A. Mixon's marketing leadership, the business broadened its activities and entered diagnostic imaging. Johnson & Johnson acquired Technicare in 1978 and subsequently placed Invacare on the market. Mixon sought to acquire the company to establish an independent business. He assembled financing through a $4.3 million loan and a further $2.5 million in fundraising, completing the $7.8 million purchase on December 28, 1979. Invacare then developed as a broader medical-equipment company, extending beyond wheelchairs into products supporting home care, rehabilitation, patient handling, pressure management and institutional care. Acquisitions played an important role in the company's expansion. By 2008, Invacare was reported to have reached a valuation of about $1.8 billion and to distribute its products through more than 25,000 medical-equipment providers in 80 countries. Its international model relied substantially on provider and distributor networks rather than only direct consumer retail. Regulatory compliance became a major part of the company's later history. In 2012, Invacare's North American operations entered into a consent decree with the federal government relating to certain products and facilities. Independent-auditor certification reports were submitted as part of the process. The FDA accepted two reports by 2013, but a 2015 follow-up inspection found that additional work was necessary in design controls and design-history documentation. In April 2017, the FDA accepted a revised second certification report, permitting the Elyria facility to resume design work. Review of a subsequent certification report remained contingent on addressing the issues identified in the earlier report. Financial and operational challenges later affected the North American business. In February 2023, Invacare stated that its North American entities had filed for Chapter 11 bankruptcy protection. The filing was limited to those entities rather than the whole international group. Invacare emerged from Chapter 11 in 2024 and continued operating across North America, Europe and Asia-Pacific, while maintaining a wider international presence. The brand's continuing scope centers on non-acute medical equipment, especially mobility, beds, seating, pressure care and safe patient handling.
- 2024
Invacare emerges from Chapter 11
[1]The company completed its North American restructuring and continued operations across several international regions.
- 2023
North American entities file for Chapter 11
[1]Invacare announced Chapter 11 proceedings for its North American entities.
- 2017
FDA accepts revised certification report
[1]The FDA accepted a revised second certification report and allowed design work to resume at the Elyria facility.
- 2012
North American consent decree begins
[1]Invacare's North American operations entered a federal consent decree involving certain products and facilities.
- 2008
International distribution network reaches major scale
[1]Following multiple acquisitions, Invacare was reported to serve more than 25,000 medical-equipment providers in 80 countries.
- 2007
Malachi Mixon receives the Harvard Business School Alumni Achievement Award
[1]Mixon was awarded Harvard Business School's Alumni Achievement Award, the school's highest alumni honor.
- 1979
Malachi Mixon acquires Invacare
[1]Mixon completed the purchase of Invacare on December 28 for $7.8 million after arranging acquisition financing.
- 1978
Technicare is acquired by Johnson & Johnson
[1]Johnson & Johnson acquired Technicare, after which Invacare was put up for sale.
- 1885
Worthington Company begins wheelchair production
[1]The manufacturing lineage later associated with Invacare begins with the Worthington Company's production of wheelchairs.
Products and positioning
A global non-acute medical-equipment provider focused on mobility, rehabilitation, independence, pressure management and caregiver support across home-care and institutional settings.
Mobility equipment
Manual wheelchairs
Manual wheelchairs are a foundational Invacare product category, covering mobility equipment for users who self-propel or require caregiver assistance. The category is associated with the company's long wheelchair-manufacturing lineage and its rehabilitation and home-care focus.
Mobility equipment
Powered wheelchairs
Powered wheelchairs provide motorized mobility for people who cannot effectively use a manual chair. They form part of Invacare's broader mobility and seating portfolio for home, community and rehabilitation use.
Mobility equipment
Mobility scooters
Invacare's mobility-scooter category supports assisted personal transport for users seeking greater independence in daily activities and community environments. It complements the company's wheelchair portfolio.
Beds and room equipment
Medical and adjustable beds
Medical and adjustable beds are designed for care environments where positioning, transfers and caregiver access are important. They extend Invacare beyond mobility into home-care and institutional equipment.
Patient handling
Safe patient-handling equipment
This category includes equipment intended to assist transfers, lifting and repositioning of patients while reducing physical strain on caregivers. It serves hospitals, care facilities and home-care settings.
Pressure management
Pressure-care systems
Pressure-care products support the prevention and management of pressure-related injury for people with limited mobility. They are part of Invacare's seating, bed and rehabilitation offering.
Seating and rehabilitation
Specialized seating and positioning
Specialized seating and positioning products are intended to improve posture, comfort, support and functional positioning for wheelchair users and people with complex rehabilitation needs.
Brand decisions
2023
North American Chapter 11 restructuringStrategyBackground
Financial pressure affected Invacare's North American entities, while the international business continued separately.
Action taken
The North American entities filed for protection under Chapter 11 in February 2023.
Aftermath
Invacare emerged from Chapter 11 in 2024 and continued operating across North America, Europe and Asia-Pacific.
2012
Regulatory consent-decree compliance programOtherBackground
Invacare's North American operations entered into a federal consent decree relating to certain products and facilities.
Action taken
The company used independent-auditor certification reports and corrective work addressing design controls and design-history documentation.
Aftermath
The FDA accepted a revised second certification report in 2017 and allowed design work to resume at the Elyria facility, while further review remained pending.
1979
Management-led acquisition of InvacareM&ABackground
After Johnson & Johnson acquired Technicare and placed Invacare on the market, Malachi Mixon sought to acquire the business and operate it independently.
Action taken
Mixon arranged acquisition financing and completed the purchase for $7.8 million on December 28, 1979.
Aftermath
The transaction established the ownership and leadership context under which Invacare developed into a broader international medical-equipment company.
Acquisition price. $7.8 million (December 28, 1979)
Recent events
Sources2 sources
Cite this profile: Cite the canonical profile. /brand-wiki/invacare · Editorial policy · How profiles are compiled